Vaccinex, Inc. (VCNX) stock price moved -12.69% away from 20-Days Simple Moving Average, -13.72% from 50-Days Simple Moving Average and separated -39.01% from 200 Days Simple Moving Average. Vaccinex, Inc. (VCNX) reported loss -2.50% in recent buying and selling session with closing price of $ 3.90. The stock’s traded 0.01 million shares in session while it holds an average volume of 0.01 million shares. The VCNX switched 17.47% away from its 52 week minimum and distanced -67.50% from its 52 week peak. The volatility change in the previous week has observed by 12.36% and experienced of 9.86% change in the last month.
The short ratio in the company’s stock is documented at 0.99 and the short float is around of 0.31%. The Company kept a record of 1.75 million floated shares and 10.37 million shares outstanding. The average true range of the stock is observed at 0.44 and the relative strength index of the stock is recorded at 41.85.
Vaccinex, Inc. (VCNX) Stock Profitability Levels:
Gross profit margin is -43.90%. The larger the gross profit margin, the better for the company.
Analyst established EPS growth expected to grow of 16.40% for this year and EPS growth for next year is likely to attain at 43.80%.
Looking about the past performance history, the company plunged -6.47% for the last five trades and exhausted -22.62% in one month period. The stock deteriorated -25.71% during the past three month period and discounted -60.88% in half year. During the yearly overview it upgraded and shown 7.00% year to date performance.